"algemeen ziekenhuis met campussen te Dendermonde en Zele"

During the past decade, AZ Sint Blasius conducted 56 clinical trials. In the 10-year time frame, 56 clinical trials started and 17 clinical trials were completed, i.e. on average, 30.4% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 8 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AZ Sint Blasius" #1 sponsor was "Flanders Medical Research Program" with 24 trials, followed by "ID3 Medical" with 11 trials sponsored, "Boston Scientific Corporation" with 6 trials sponsored, "Biotronik AG" with 4 trials sponsored and "Boehringer Ingelheim" with 4 trials sponsored. Other sponsors include 40 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AZ Sint Blasius" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "AZ Sint-Blasius Dendermonde" with 2 trials as a collaborator, "CyndRx, LLC" with 2 trials as a collaborator, "AZ Damiaan, Oostende" with 1 trials as a collaborator and "AZ Sint-Jan AV" with 1 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "AZ Sint Blasius" are "Peripheral Arterial Disease" (32 trials), "Peripheral Vascular Disease" (13 trials), "Critical Limb Ischemia" (7 trials), "Peripheral Artery Disease" (5 trials) and "Atherosclerosis" (4 trials). Many other conditions were trialed in "AZ Sint Blasius" in a lesser frequency.

Most popular intervention types in "AZ Sint Blasius" are "Device" (64 trials), "Drug" (14 trials), "Other" (5 trials), "Procedure" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Empagliflozin" (3 trials), "Gantenerumab" (2 trials), "Stent implantation" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "AZ Sint Blasius" are 87 trials for "All" genders, 4 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "AZ Sint Blasius". 1 are not yet recruiting, 7 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 59 completed trials in AZ Sint Blasius, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in AZ Sint Blasius, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 16 trials, and there were also 35 trials that are defined as “Not Applicable".

AZ Sint Blasius has several departments that took part in Clinical trials: "AZ Sint-Blasius, Cardiology, Dendermonde" - 2 trials